The risk factors associated with MERS-CoV patient fatality: A global survey

Diagnostic Microbiology and Infectious Disease

Volumn 96, Issue 3, 2020, Pages

  Ahmadzadeh, Jamal ^a   Mobaraki, Kazhal ^a   Mousavi, Seyed Jalil ^a   Aghazadeh Attari, Javad ^a   Mirza Aghazadeh Attari, Mohammad ^b   Mohebbi, Iraj ^a  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Case fatality rate; Emerging infectious disease; Epidemiology; Middle East respiratory syndrome coronavirus

Indexed keywords

ADULT; ARTICLE; CASE FATALITY RATE; CAUSE OF DEATH; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST RESPIRATORY SYNDROME; MORBIDITY; MORTALITY RATE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SAUDI ARABIA; ADOLESCENT; CHILD; CORONAVIRUS INFECTION; GLOBAL HEALTH; INFANT; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MORTALITY; PRESCHOOL CHILD; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CORONAVIRUS INFECTIONS; FEMALE; GLOBAL HEALTH; HUMANS; INFANT; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; RISK FACTORS; YOUNG ADULT;

EID: 85078036304     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2019.114876     Document Type: Article

References (29)

1. Cowling, B.J., Park, M., Fang, V.J., Wu, P., Leung, G.M., Wu, J.T., Preliminary epidemiologic assessment of MERS-CoV outbreak in South Korea, May–June 2015. Euro surveillance: bulletin Europeen sur les maladies transmissibles – European communicable disease bulletin, 20(25), 2015.
2. Alamoudi, R.J., Azhar, L.E., Alamoudi, D.H., Alamoudi, D.H., Tolah, A.M., Alhabbab, R.Y., et al. No molecular evidence of MERS-CoV circulation in Jeddah, Saudi Arabia between 2010–2012: a single-center retrospective study. The Journal of Infection in Developing Countries 12:05 (2018), 390–393.
3. Alghamdi, I.G., Hussain, I.I., Almalki, S.S., Alghamdi, M.S., Alghamdi, M.M., El-Sheemy, M.A., The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health. International journal of general medicine, 7, 2014, 417.
4. Alraddadi, B.M., Al-Salmi, H.S., Jacobs-Slifka, K., Slayton, R.B., Estivariz, C.F., Geller, A.I., et al. Risk factors for Middle East respiratory syndrome coronavirus infection among healthcare personnel. Emerg Infect Dis, 22(11), 2016, 1915.
5. Alshahrani, M.S., Sindi, A., Alshamsi, F., Al-Omari, A., El Tahan, M., Alahmadi, B., et al. Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus. Ann Intensive Care, 8(1), 2018, 3.
6. Alzeer, A.H., Respiratory tract infection during hajj. Annals of thoracic medicine, 4(2), 2009, 50.
7. Assiri, A., McGeer, A., Perl, T.M., Price, C.S., Al Rabeeah, A.A., Cummings, D.A., et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. New England Journal of Medicine 369:5 (2013), 407–416.
8. Castaño-Rodriguez C, Honrubia JM, Gutiérrez-Álvarez J, DeDiego ML, Nieto-Torres JL, Jimenez-Guardeño JM, et al. Role of severe acute respiratory syndrome coronavirus Viroporins E, 3a, and 8a in replication and pathogenesis. MBio 2018;9(3):e02325–17.
9. Cong, Y., Hart, B.J., Gross, R., Zhou, H., Frieman, M., Bollinger, L., et al. MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells. PloS one, 13(3), 2018, e0194868.
10. Conzade, R., Grant, R., Malik, M., Elkholy, A., Elhakim, M., Samhouri, D., et al. Reported direct and indirect contact with dromedary camels among laboratory-confirmed MERS-CoV cases. Viruses, 10(8), 2018, 425.
11. Gautret P, Charrel R, Belhouchat K, Drali T, Benkouiten S, Nougairede A, et al. Lack of nasal carriage of novel corona virus (HCoV-EMC) in French hajj pilgrims returning from the hajj 2012, despite a high rate of respiratory symptoms. Clin Microbiol Infect 2013;19(7):E315-E7.
12. Harrath, R., Abu Duhier, F.M., Sero-prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) specific antibodies in dromedary camels in Tabuk, Saudi Arabia. J Med Virol 90:8 (2018), 1285–1289.
13. Harriman, K., Brosseau, L., Trivedi, K., Hospital-associated Middle East respiratory syndrome coronavirus infections. N Engl J Med, 369(18), 2013, 1761.
14. Hu, B., Ge, X., Wang, L.-F., Shi, Z., Bat origin of human coronaviruses. Virol J, 12(1), 2015, 221.
15. Hunter, J.C., Nguyen, D., Aden, B., Al Bandar, Z., Al Dhaheri, W., Elkheir, K.A., et al. Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi. Emerg Infect Dis, 22(4), 2016, 647.
16. Kamau, E., Ongus, J., Gitau, G., Galgalo, T., Lowther, S.A., Bitek, A., et al. Knowledge and practices regarding Middle East respiratory syndrome coronavirus among camel handlers in a slaughterhouse, Kenya, 2015. Zoonoses Public Health 66:1 (2018), 169–173.
17. Kazhal Mobaraki, K., Ahmadzadeh, J., An update to middle east respiratory syndrome coronavirus and risk of a pandemic in 2019. Clinical Microbiology and Infectious Diseases, 4(1), 2019, 2.
18. Lessler, J., Salje, H., Van Kerkhove, M.D., Ferguson, N.M., Cauchemez, S., Rodriquez-Barraquer, I., et al. Estimating the severity and subclinical burden of Middle East respiratory syndrome coronavirus infection in the Kingdom of Saudi Arabia. Am J Epidemiol 183:7 (2016), 657–663.
19. Majumder, M.S., Kluberg, S.A., Mekaru, S.R., Brownstein, J.S., Mortality risk factors for Middle East respiratory syndrome outbreak, South Korea, 2015. Emerg Infect Dis, 21(11), 2015, 2088.
20. Memish, Z.A., Zumla, A.I., Al-Hakeem, R.F., Al-Rabeeah, A.A., Stephens, G.M., Family cluster of Middle East respiratory syndrome coronavirus infections. New England Journal of Medicine 368:26 (2013), 2487–2494.
21. Memish, Z.A., Almasri, M., Turkestani, A., Al-Shangiti, A.M., Yezli, S., Etiology of severe community-acquired pneumonia during the 2013 hajj—part of the MERS-CoV surveillance program. Int J Infect Dis 25 (2014), 186–190.
22. Mobaraki, K., Ahmadzadeh, J., Current epidemiological status of Middle East respiratory syndrome coronavirus in the world from 1.1. 2017 to 17.1. 2018: a cross-sectional study. BMC Infect Dis, 19(1), 2019, 351.
23. Mobaraki, K., Ahmadzadeh, J., An update to middle east respiratory syndrome coronavirus and risk of a pandemic in 2019. Clinical Microbiology and Infectious Diseases 4:1 (2019), 1–2.
24. Park, J.W., Lee, K.J., Lee, K.H., Lee, S.H., Cho, J.R., Mo, J.W., et al. Hospital outbreaks of middle east respiratory syndrome, Daejeon, South Korea, 2015. Emerg Infect Dis, 23(6), 2017, 898.
25. Petersen, E., Pollack, M.M., Madoff, L.C., Health-care associate transmission of Middle East respiratory syndrome corona virus, MERS-CoV, in the Kingdom of Saudi Arabia. Int J Infect Dis 29 (2014), 299–300.
26. Sherbini, N., Iskandrani, A., Kharaba, A., Khalid, G., Abduljawad, M., Hamdan, A.-J., Middle East respiratory syndrome coronavirus in Al-Madinah City, Saudi Arabia: demographic, clinical and survival data. Journal of epidemiology and global health 7:1 (2017), 29–36.
27. Wang, Q., Qi, J., Yuan, Y., Xuan, Y., Han, P., Wan, Y., et al. Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26. Cell Host Microbe 16:3 (2014), 328–337.
28. World Health Organization, Emergencies preparedness, response:MERS-CoV.Disease outbreak news. Available from http://www.who.int/csr/don/archive/disease/coronavirus_infections/en/, 2019.
29. Zumla, A., Hui, D.S., Perlman, S., Middle East respiratory syndrome. The Lancet 386:9997 (2015), 995–1007.